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Introduction
The appropriate management of critically ill patients who present 
with acute kidney injury (AKI) is paramount. The management of this 
patient population is probably more complicated than that of chronic 
care haemodialysis (HD) patients, as AKI patients have significant 
protein catabolism, insulin resistance (abnormal carbohydrate 
metabolism) and an altered fat metabolism, and AKI patients on 
continuous renal replacement therapy (CRRT), such as continuous 
venovenous haemofiltration (CVVH), are at greater risk of protein and 
micronutrient losses. The primary goals of nutritional management 
of AKI patients are to attenuate protein (muscle) catabolism and to 
replace micronutrient losses, while being mindful of the potential 
harmful effects of excessive vitamin C and vitamin A in retinol form.1 
The majority of intensive care units (ICUs) in South Africa do not 
have scale beds to accurately determine actual body weight which 
is required to calculate fluid and nitrogen balance. The calculation 
of nitrogen balance (an adapted formula for AKI) is required for 
the calculation of the appropriate dose of protein (patient-specific 
prescription). A grade E recommendation [supported by level IV 
(nonrandomised, historical controls) or level V evidence (case series, 
uncontrolled studies and expert opinion)] has been proposed for 
patients with AKI. It states that “in ICU patients with AKI, standard 
ICU recommendations for energy and protein should be followed, 
and (these patients) should receive a standard enteral formulation. 
Unless electrolyte abnormalities exist or develop, a specialised 
renal formulation may be considered”.2 The focus of this review 
will be on the nutritional management of AKI patients requiring 
renal replacement therapy (RRT), i.e. AKI patients requiring more 
specialised dietary management. Until recently, few HD oral enteral 
feeds (high protein, with low electrolytes and limited volume) were 
available in South Africa. Currently, specialised HD ready-to-hang 
enteral feeds tube feeding for AKI patients on RRT in ICU are not 
available in South Africa. Decanting the oral feeds for tube feeding 
is labour intensive for the nursing staff, and such practice lacks 
the sterility of a closed system (personal observation). Some of the 
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enteral feeds, not necessarily the HD-specific feeds, used for HD 
patients in ICUs in South Africa, are too high in vitamin C and the 
retinol form of vitamin A, and too low in folic acid.
A good understanding of the classification of patients with AKI, 
the types of RRT used in the management of these patients, the 
specialised macronutrient and micronutrient requirements, and 
appropriate fluid management of AKI patients is required for 
appropriate dietary management of critically ill AKI patients. The aim 
of this review is to address these.
Definitions
There are over 35 different definitions of acute renal failure; referred 
to as AKI in recent years. 3 AKI is an abrupt and sustained reduction 
in kidney function, defined as:
•	 An increase in serum creatinine by 50% within seven days, or
•	 An increase in serum creatinine by 0.3 mg/dl (26.5 umol/l) within 
two days, or
•	 Oliguria.4 
AKI may be due to isolated kidney dysfunction, or it may be a 
complication of severe illness.5 
Classification of acute kidney injury
Patient groups based on severity of disease
Valencia et al5 have classified AKI in three patient group categories 
according to level of catabolism and disease severity. 
Group 1
Group 1 comprises patients without excess catabolism and a 
urea nitrogen appearance (UNA) of 6 g or less nitrogen loss than 
the nitrogen intake per day. AKI is mainly caused by nephrotoxins 
(aminoglycosides, contrast media and mismatched blood 
transfusions) in this group. In most cases, these patients are fed 
enterally and the prognosis for renal function recovery and survival 
is excellent.5  
Group 2
Group 2 comprises patients with moderate catabolism and a UNA 
of 6-12 g nitrogen loss more than the nitrogen intake per day. This 
group of patients frequently has complicating infections, peritonitis 
or moderate injury, in association with AKI. Patients require enteral 
feeding or total parenteral nutrition (TPN), and usually dialysis or 
haemofiltration to limit waste product accumulation.5 
Group 3
Group 3 comprises patients with severe catabolism and a UNA 
of more than 12 g nitrogen loss than the nitrogen intake per day. 
This group of patients frequently has severe trauma, burns or 
overwhelming infection, in association with AKI. Treatment strategies 
are usually complex and include parenteral nutrition, haemofiltration 
(intermittent or continuous), as well as blood pressure and ventilatory 
support.5 
To reduce catabolism and avoid protein depletion in group 3 patients, 
nutrient requirements, specifically protein, are high, and dialysis is 
used to maintain fluid balance and blood urea nitrogen (BUN) below 
100 mg/l. Mortality in this group is high (60-80%), mainly due to 
a combination of renal dysfunction, hypercatabolism, inflammatory 
reaction and the severity of the underlying illness.5   
The RIFLE and Acute Kidney Injury Network classifications
Currently, the most widely used classification for AKI is the RIFLE 
model (risk, injury, failure, loss and end-stage renal disease), 
which was proposed by the Acute Dialysis Quality Initiative group.6 
A second model that is commonly used is the Acute Kidney Injury 
Network (AKIN) staging system, which is a modification of the RIFLE 
classification. Both models are based on serum creatinine and urine 
output, and both have been validated. In a recent study conducted 
by Joannidis et al,7 it was observed that the RIFLE criteria failed to 
detect 9% of AKI that was detected by the AKIN criteria, while the 
AKIN criteria failed to detect 26.9% of AKI cases detected by RIFLE. 
Despite the validation of both models, in clinical practice, oliguria 
appears to be the main factor that is considered by clinicians when 
deciding whether or not to initiate RRT. As demonstrated in the study 
conducted by Bellomo et al,8 the decision to initiate RRT was based 
on oliguria in 60% of the patients.
RIFLE classification
The RIFLE classification is defined in Table I.5
Table I: RIFLE classification of renal failure5
Class Serum creatinine or GFR 
criteria
Urine output criteria
Risk (stage 1) Serum creatinine x 1.5 or GFR 
decreased by > 25%
< 0.5 ml/kg/hour for  
6 hours
Injury (stage 2) Serum creatinine x 2 or GFR 
decreased by > 50%
< 0.5 ml/kg/hour for  
12 hours
Failure (stage 3) Serum creatinine x 3 or 
serum creatinine ≥ 4 mg/dl 
(354 mmol/l) with an acute 
rise > 0.5 mg/dl (44 mmol/l)
< 0.3 ml/kg/hour for  
24 hours, or anuria 
for 12 hours
Loss Persistent acute renal failure 
equals complete loss of 
kidney function (> 4 weeks)
End-stage kidney 
disease
End-stage kidney disease  
(> 3 months)
GFR: glomerular filtration rate
Acute Kidney Injury Network criteria
The AKIN criteria have similar urine output criteria to the RIFLE 
classification, but differ in the serum creatinine levels, as defined 
in Table II.
The proposed staging system is a highly sensitive interim staging 
system, and is based on recent data indicating that a small change in 
serum creatinine influences outcome. Only one criterion (creatinine 
or urine output) has to be fulfilled to qualify for a stage.
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Common causes of acute kidney injury
The most common causes of AKI include sepsis, major surgery, low 
cardiac output and hypovolaemia. Other common causes of AKI are 
listed in Table III. 3
Common nephrotoxins that cause acute kidney injury




•	 Radiocontrast	dye: For example, that used for angiograms.
•	 Ingestions: For example, ethylene glycol (found in anti-freeze 
brake fluid, coolants and solvents) and paracetamol. These 
ingestions are examples of those taken by parasuicide patients.
•	 Medications: Chemotherapeutic agents, nonsteroidal anti-
inflammatory drugs, antimicrobial medicines, aminoglycoside 




•	 Haemolysis: Haemolytic uraemic syndrome and thrombotic 
thrombocytopenic purpura. 
•	 Tumour lysis syndrome.3
Onset of acute kidney injury
It was observed in a retrospective study on 5 383 ICU patients that 
the majority of patients developed AKI in ICU. However, in some 
cases AKI occurred post discharge from the ICU.10		
Types of dialysis
There are three types of RRT; peritoneal dialysis (PD), HD and CRRT, 
which is administered continuously over 18-24 hours. There are two 
modes of HD, namely intermittent HD which is usually performed 
every second day for 4-6 hours, and sustained low-efficiency 
dialysis  which is performed for 8-12 hours, 5-6 days a week.11 There 
are two types of CRRT, namely CVVH and continuous venovenous 
haemodiafiltration (CVVHDF). It is important to have a good 
understanding of the various forms of renal replacement therapy, 
as each has a varying impact on the nutritional requirements for 
critically ill AKI patients.12	
AKI requiring dialysis in critically ill patients is associated with a 
mortality of 40-70%, and the disease itself is an independent risk 
factor for death.12 
Intermittent HD is perhaps the most commonly used form of RRT 
in critically ill patients. Intermittent HD is less expensive than CRRT 
and has similar efficacy.13 CRRT is used for patients who require 
dialysis, but who are haemodynamically unstable, and/or fluid 
overloaded, and hence cannot afford to have a rapid change in total 
fluid volume.6	It was observed in a study carried out by Salahudeen 
et al11 that more aggressive and early nutritional support may be 
important to survival in patients on CRRT. 
Continuous venovenous haemofiltration circuit
The patient’s blood is pumped and anticoagulated before passing 
to the haemofilter. A drip chamber acts as a bubble trap before 
the blood is returned to the patient. The ultrafiltration rate and 
resultant solute convection are dependent upon the speed of the 
blood pump and consequent transmembrane pressure generated. 
Multiple pressure sensors assist in monitoring transmembrane 
pressure, for example. CVVH blood flow is 0-300 ml per minute. The 
ultrafiltration rate is 0-35 ml/kilogram body weight/hour. However, in 
clinical practice, the average rate used is usually 20-35 ml/kg/hour. 
A calculated proportion of ultrafiltrate is replaced with replacement 
fluid to achieve the desired fluid balance, except in patients with 
fluid overload or cardiopulmonary dysfunction, when a negative fluid 
balance needs to be achieved.12	
Continuous venovenous haemodiafiltration circuit 
A CVVHDF circuit is similar to CVVH, but with the addition of a 
counter-current dialysate fluid flow through the haemofilter. This 
Table II: Acute Kidney Injury Network staging system9
Stage Serum creatinine Urine output
1*  An increase in serum creatinine of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l), or an 
increase to more than or equal to 150-200% (1.5 to 2-fold) from baseline
Less than 0.5 ml/kg/hour for more than six hours
2 An increase in serum creatinine to more than 200-300% (> 2- to 3-fold) from baseline Less than 0.5 ml/kg/hour for more than 12 hours
3** An increase in serum creatinine to more than 300% (> 3-fold) from baseline, or serum 
creatinine of more than or equal to 4 mg/dl (≥ 354 μmol/l) with an acute increase of at least 
0.5 mg/dl (44 μmol/l)
Less than 0.3 ml/kg/hour for 24 hours or anuria for 
12 hours
*Modified from the RIFLE (risk, injury, failure, loss and end-stage kidney disease) criteria
**Given the wide variation in indications and the timing of the initiation of renal replacement therapy, individuals who receive renal replacement therapy are considered to have met the criteria for stage 3, 
irrespective of the stage at which they are in at the time of renal replacement therapy
Table III: Common causes of acute kidney injury3
The most common causes of 
acute kidney injury
Other common causes of acute 
kidney injury
•	 Sepsis (most common)
•	 Major surgery






•	 Abdominal compartment 
syndrome
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allows for both convective and diffuse flow to occur, and hence an 
increase in the rate of solute clearance. 12 
Intermittent haemodialysis circuit
Intermittent HD depends on diffusive solute clearance owing to the 
counter-current flow of dialysate fluid through the haemofilter. The 
blood flow rate within the circuit is higher, and high dialysate flow 
produces large filtration volumes. Unlike CVVH, no replacement fluid 
is required as rapid solute removal is achieved with less total fluid 
loss from the patient.12 The average human has a total blood volume 
of five litres.14 
Absolute indications for renal replacement therapy
The following are absolute indications for RRT:
•	 Uraemic	 complications: Encephalopathy, pericarditis and 
bleeding.
•	 Serum urea ≥ 36 mmol/l.
•	 Potassium > 6 mmol/l or electrocardiogram abnormalities.
•	 Serum pH ≤ 7.15.
•	 Urine output less than 200 ml/12 hours or anuria.
•	 Diuretic-resistant organ oedema, especially pulmonary oedema, 
in the presence of AKI.15
Goals of nutritional support 
The goals of nutritional support in AKI are the following: 
•	 To prevent protein energy wasting.
•	 To preserve lean body mass and nutritional status.
•	 To avoid further metabolic derangement.
•	 To avoid complications.
•	 To improve wound healing.
•	 To support immune function.
•	 To minimise inflammation.
•	 To improve antioxidant activity.
•	 To improve endothelial function.
•	 To reduce or prevent mortality.16 
Energy requirements
Internationally, the recommended guideline for calculating energy 
requirements for AKI is 25-35 Kcal/kg/day (total energy). 4 However, 
in practice, 20-30 Kcal/kg/day is more achievable.2,17 Energy 
expenditure in critically ill patients with AKI rarely exceeds 1.3 times 
the basal energy requirements.16,18	Fiaccadori	et al16	 reported	 that 
benefit was not shown in the nitrogen balance if more than 35 Kcal/
kg/day was administered.
Protein requirements
Whole body protein synthesis increases by 15-37% in critically 
ill patients. However, protein breakdown increases by 41-79%, 
resulting in net protein catabolism. Unabated protein catabolism 
during critical illness, because of inadequate nutrition therapy, will 
result in impaired immunity, increased risk of infection and might 
worsen mortality risk.19 
In addition to stress mediators, immobility and physical inactivity are 
key determinants of anabolic resistance in critically ill patients. The 
development of mobility protocols in the ICU should be promoted to 
enhance the efficacy of nutrition.20 
Pathogenesis of protein catabolism in acute kidney injury
Multiple factors can potentially aggravate the pathogenesis of 
protein catabolism in AKI, namely:
•	 An inadequate supply of nutrients.
•	 Uraemic toxins.
•	 Endocrine factors.
•	 A defective response to insulin (resistance).
•	 The increased secretion of catabolic hormones (glucagon, 
catecholamines and glucocorticoids).
•	 Resistance to, or suppression of, growth or anabolic factors.	
•	 Acute phase response or systemic inflammatory response 
(cytokines).
•	 Metabolic acidosis.
•	 Proteases (the ubiquitine-proteasome system).
•	 Loss of nutritional substrates during RRT.16 
Approximately 0.2 g amino acid is lost per litre of filtrate in CRRT, 
resulting in a total loss of 10-15 g amino acid (protein) per day. An 
additional 5-10 g of protein is lost per day depending on the type of 
therapy and dialyser membrane.2 
The optimum protein requirement for intermittent HD is 1.2- 
1.5 g/kg ideal body weight.17 The optimum protein requirement 
for CRRT and hypercatabolic patients is 1.7 g/kg/day.4 Fiaccadori 
et al22	 recommend a maximum of 2 g/kg/day for hypercatabolic 
AKI patients and/or those who are on CRRT. In practice, the latter 
recommendation is difficult to implement practically, especially if a 
fluid restriction (due to severe fluid overload and cardiopulmonary 
failure) is required in such patients (personal observation). The 
recommended protein requirement in AKI patients who are not yet 
on RRT varies from 0.6-0.8 g2,13 and 0.8-1 g protein/kg/day.4,22 Refer 
to Table IV for a case example of the protein requirements for an AKI 
patient, either not on RRT, or on intermittent HD or on CRRT.
Assessment of adequacy of protein prescribed 
The standard nitrogen balance calculation method usually 
utilised for critically ill patients requires a creatinine clearance of 
50 ml/minute/1.73m2, and is hence not reliable for AKI. In AKI, UNA 
and protein catabolic rate (PCR) are more accurate. 
The formulae for calculating UNA and PCR are provided below: 17 
UNA g/day = UUN + [(BUN2 – BUN1) x 0.6 x BWI] + (BW2 – BW1) 
x BUN2]
PCR g/day = UNA x 6.25
BUN1: Initial collection of blood urea nitrogen, post dialysis (g/l)
BUN2: Final collection of blood urea nitrogen, pre-dialysis (g/l)
BW1: Post-dialysis weight (kg)
BW2: Pre-dialysis weight (kg)
UUN: Urinary urea nitrogen (g/day).13
Table IV: Case example of the protein requirements for an acute kidney 
patient patient, either not on renal replacement therapy, or on intermittent 
haemodialysis or on continuous renal replacement therapy
The calculation of protein requirements for a patient weighing 70 kg:
•	 Not	on	RRT: 0.6-1 g x 70 kg = 42-70 g protein/day.
•	 Intermittent	dialysis: 1.2-1.5 g (1.3 g) x 70 kg = 84-105 g protein/day.
•	 CRRT: 1.7-2 g x 70 kg = 119-140 g protein/day.
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A UNA of 5-10 g per day suggests moderate catabolism, while a 
UNA of greater than 10 g per day suggests severe catabolism.18	
A practical limiting factor in determining UNA and PCR is that an 
accurate pre- and post- dialysis actual body weight are required. If 
an ICU scale bed or Bluetooth bed scale is not available to accurately 
measure actual body weight, the UNA and PCR cannot be calculated, 
and hence individualised protein requirements cannot be accurately 
determined.
Carbohydrate requirements
Carbohydrate requirements have not yet been accurately established 
for critically ill patients. The theoretical estimation of the maximum 
oxidation rate of glucose is 4-7 mg/kg/minute (or 400-700 g/day 
for a 70 kg patient). The latter should not be confused with ideal 
carbohydrate requirements for ICU patients, required to achieve 
blood sugar levels between 4.5 mmol/l and 6.1mmol/l, which have 
been shown to reduce mortality rates in ICU patients. To meet the 
requirements of the brain, the minimum daily requirement of glucose 
is estimated to be 100-120 g per day.21 Carbohydrate, in the form of 
citrate, glucose and lactate from intravenous fluids, as well as from 
dialysate or haemofiltration solutions, also needs to be considered 
with regard to the total carbohydrate and energy daily intake to 
ensure normoglycaemia.22
Avoiding hyperglycaemia
Stress-induced hyperglycaemia in critically ill patients occurs 
due to the impairment of insulin-mediated glucose uptake in the 
skeletal muscles and the failure of insulin to suppress hepatic 
gluconeogenesis.18	 Patients with AKI are more prone to have 
exacerbated insulin resistance	due to losses of renal gluconeogenesis 
and hormonal clearances (mainly insulin and glucagon).23	 Under 
normal conditions, 30% of insulin catabolism occurs in the kidneys.18 
Some studies have suggested a better outcome for AKI patients with 
tighter blood sugar control, using insulin infusion protocols.3,21 Hence, 
it would be	prudent to be more cautious regarding the amount of 
carbohydrate prescribed and to ensure that the administration rates 
of high carbohydrate enteral feeds or TPN (especially if greater than 
250 g/day) are administered at a lower rate, to aid more stringent 
glycaemic control (personal observation).	 Infusion insulin therapy 
which targets plasma glucose at 6.1-8.3 mmol/l is recommended in 
critically ill AKI patients with elevated blood sugar. Tight glycaemic 
control has been shown to reduce the incidence of severe AKI.4
Fat requirements
AKI patients are prone to elevated plasma triglyercides (TGs) 
and elevated very low-density lipoprotein (LDL) levels, as well 
as, decreased levels of total cholesterol, LDL and high-density 
lipoprotein (HDL). Impaired lipolysis is the most important cause 
of plasma changes in AKI, as both peripheral lipoprotein lipase and 
hepatic triglyceride lipase are reduced by approximately 50%, and 
lipoprotein lipase activity is further inhibited if acidosis coexists in 
patients with AKI.18 
Ideally, 30-35% of total energy should be provided in the form of fat. 
A further more specific suggested dose of fat (intravenously) per day 
been recommended, i.e. 0.8-1.2 g per kilogram body weight. It is 
important to monitor serum TGs, and to reduce or stop fat intake if 
the TGs exceeds 400 mg/dl (4.5 mmol/l). The provision of fat in the 
form of a combination of medium-chain TGs and long-chain TGs may 
aid in preventing elevated TGs in AKI.18
Special micronutrient requirements
Patients with AKI on RRT have specific micronutrient requirements. 
Excessive amounts of vitamin C and retinol, for example, may be 
deleterious to these patients, while they may also be at greater 
risk of folic acid, thiamine, selenium and copper deficiencies, and 
require greater amounts of these nutrients than the standard daily 
allowance.2,16
Vitamin C
Vitamin C is converted to oxalate, a renal toxin in renal failure. 
Oxalate is not adequately removed by RRT, accumulates in the renal 
tubules, and thus exacerbates the existing AKI and potentially limits 
renal recovery. Hence, it is paramount to limit vitamin C to 100 mg in 
intermittent HD and 100-200 mg for CRRT.2,17,18 
Table V: Enteral feed product micronutrient and fibre nutritional profiles




Renilon® 7.5 Peptamen® AF Survimed® HN
Volume 1 000 ml 1 000 ml 1 000 ml 1 000 ml 1 000 ml 1 000 ml
Sodium 779 mg 1 060 mg 1 600 mg 590 mg 1 000 mg 1 350 mg
Potassium 1 119 mg 1 060 mg 1 100 mg 220 mg 2 300 mg 2 600 mg
Phosphorus 740 mg 720 mg 650 mg 30 mg 840 mg 720 mg
Fibre 0 g 4.2 g 0 g 0g 0 g
L-carnitine 162 mg 265 mg 270 mg 150 mg - 0 mg
Folic acid 426 µg 1 060 µg 1 000 µg 1 000 µg 400 µg 400 µg
Vitamin C 106 mg 105 mg 80 mg 60 mg 180 mg 120 mg
Vitamin A
(retinol)
315 µg (RE) 954 µg (RE) 990 µg (RE) 0 µg 1 480 µg 105 µg
Beta-carotene Not specified Not specified Not specified 4.5 µg 220 µg 200 µg
*Was recently discontinued in South Africa, and replaced with Nepro® Low Protein
**Currently not available in ready-to-hang format, and only available in sip-feed format, in South Africa
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During CRRT, approximately 100 mg of vitamin C is lost per day in 
the ultrafiltrate.24 Refer to Table V for the vitamin C content of specific 
enteral feeds used in the management of ICU AKI patients on dialysis.
Folic acid
Approximately 265 µg of folic acid per day is lost in the ultrafiltrate 
during CRRT.24 Supplementation with 1 mg per day of folic acid is 
recommended in ischaemic heart disease and CRRT.17 Some of the 
specialised renal enteral feeds contain 1 mg folic acid per litre, 
and hence additional supplementation is unnecessary, while other 
specialised renal enteral products only contain 400 µg (personal 
observation). Refer to Table V for the folic acid content of various 
enteral feeds used to treat patients undergoing RRT.
Thiamine and selenium
Prolonged CRRT also results in increased selenium and thiamine 
losses.24 Supplementation with 25-100 mg of thiamine per day is 
recommended in AKI patients on CRRT.2 Supplementation with 1.5 
times the normal daily requirement for selenium, or 100 µg/day, is 
recommended for AKI patients on CRRT.16,17
Vitamin D
Vitamin D deficiency has been reported to be significantly associated 
with an increase in AKI in the critically ill population. The risk of 
mortality is 1.4 times higher in the vitamin D-insufficient, and 1.6 
times higher in the vitamin D-deficient critically ill, patient group.25 
Vitamin D deficiency is defined by a serum 25-hydroxvitamin D 
[25(OH)D] below 20 ng/ml (50 nmol), and vitamin D insufficiency 
as a serum 25(OH)D of 20-30 ng/ml (50-75 nmol/l). Normal 
vitamin D status is defined as above 30 ng/ml (75 nmol/l). 
1,25-dihydroxyvitamin D [1,25(OH)D] (calcitriol), the active form 
of vitamin D levels, is regulated by the parathyroid hormone, and 
reflects renal hydroxlase activity, but not body vitamin D stores. The 
1,25(OH)D levels may remain within the normal range until a severe 
degree of vitamin D deficiency is reached.26 
Vitamin D has an important role in calcium and phosphorus 
homeostasis, and also in cell growth and regulation, immune 
function, renin-angiotensin and neuromuscular regulation, as well 
as the up- and downregulation of over 2 000 genes.26
The daily dose of intravenous 200 IU vitamin D2 (cholecalciferol) 
usually prescribed for hospitalised patients has been shown to be 
ineffective in normalising vitamin D concentrations in patients who 
are vitamin D deficient. Recent studies in which high-dose vitamin 
D therapy [60 000 IU 25(OH)D x two doses] was administered to 
critically ill patients, demonstrated significant increases in serum 
25(OH)D.25 
The risks of vitamin D supplementation (> 10 000-40 000 IU per day) 
taken for an extended period, include hypercalcaemia, hypercalciuria 
and acute renal failure. Optimal vitamin D supplementation in critically 
ill patients with AKI has not yet been established. Further research 
is required to establish whether or not vitamin D supplementation 
improves organ function and mortality in critically ill patients.26
Vitamin A
Vitamin A toxicity (hypervitaminosis A) due to increased plasma 
retinol levels as a result of the loss of renal degradation of retinal-
binding protein in renal failure, occurs in patients on prolonged 
RRT.16 It is recommended that the retinol administered to AKI patients 
(especially in prolonged AKI) is limited to 700-900 µg per day.17	Refer 
to Table V for the retinol content of various enteral feeds used to treat 
patients undergoing RRT.
Phosphorus
The incidence of hypophosphataemia is prevalent in ICU patients, 
and can be further aggravated by prolonged RRT. Severe 
hypophosphataemia has been associated with respiratory muscle 
weakness and phosphate depletion, ventilator failure, myocardial 
dysfunction and encephalopathy. A bolus intravenous treatment 
dose of 20-30 mmol parenteral sodium phosphorus can be added 
to replacement or dialysate solutions.17,22 However, prescribed 
phosphorus should be limited to 10-15 mg per kilogram per day, to 
prevent hyperphosphataemia. 27
Copper
Approximately 400 µg of copper is lost during CRRT, and hence an 
intake of 300-500 µg per day is recommended. However, copper 
should be withheld from nutritional support when the total bilirubin 
is greater than 3 mg/dl.17
Zinc
A positive zinc balance may occur during CRRT from zinc contaminant 
in CRRT replacement fluid and may be due to the citrate anticoagulant 
used in CRRT. Hence, standard nutrition doses are recommended, 
unless significant gastrointestinal losses occur.17  
Fluid management
The kidneys usually receive 25% of the total cardiac output, and 
hence are very sensitive to hypoperfusion or hypovolaemia.3 Fluid 
overload is associated with an increased risk of death.13 Trends 
demonstrate improved outcomes with more stringent maintenance 
of fluid intake and output daily balances. The management of the 
critically ill is a dynamic process, and requires frequent assessment 
and adjustment to fluid volumes. Synthetic colloids, i.e. hydroxethyl 
starches and dextrans, are still widely used despite concerns 
regarding renal outcomes.3
Route of feeding
Enteral feeding of critically ill AKI patients may be challenging 
because of impaired gastrointestinal motility and the decreased 
absorption of nutrients secondary to bowel oedema. AKI is a major 
risk factor for gastrointestinal haemorrhage. Hence, enteral feeding 
may potentially exert a protective effect in reducing the risk of stress 
ulcers or bleeding.2 Enteral nutrition has been shown to augment 
renal plasma flow and improve renal function in experimental AKI.28 
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When sufficient enteral feeding cannot be achieved, a combination of 
enteral and parenteral feeding may be required to achieve successful 
nutritional support. Hence, the two routes of feeding should be 
considered as complementary, and not mutually exclusive.22 Current 
available clinical practice guidelines recommend enteral nutrition as 
the preferential route in the first 24-48 hours upon ICU admission, 
and if adequate enteral nutrition cannot be achieved from day 3-5, 
parenteral nutrition should be introduced.2
Conclusion
The evolution of more optimal and individualised dietary intervention 
in critically ill AKI patients will only progress in South Africa when 
ICU scale beds or Bluetooth bed scales are available in all of the 
ICUs in the country, especially those which provide RRT. The accurate 
measurement of actual body weight would also allow for tighter fluid 
management and more accurate measurement of nitrogen balance, 
so that adequate protein can be administered to AKI patients. It is also 
paramount that the appropriate (in terms of both macronutrients and 
micronutrients, especially protein, vitamin C, folic acid and vitamin 
A) specialised ready-to-hang (one-litre) enteral feeds for patients on 
HD and CRRT are made available in South Africa.
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